Geographic or ethnic differences in the occurrence of disease often provide insights into
causes of disease and possible opportunities for disease prevention. A wide variation on the …

Objective To determine the clinical features of psoriatic arthritis (PsA) in a multiethnic
Oriental population and to study the effect of ethnicity on disease patterns. Methods A …

There is a wide variation in the prevalence, incidence, and clinical manifestation of psoriatic
arthritis (PsA) across countries due to genetic and environmental factors. Data on PsA in …

Background There is limited information on the epidemiology of psoriatic arthritis (PsA) in
general and in Middle Eastern populations in particular. The aims of this study were to …

TNF inhibitors have been used in psoriasis (Pso) and psoriatic arthritis (PsA), which were
associated with increased risk of cardiac and cerebrovascular events. However, whether …

Background Few studies report estimates of cardiovascular disease (CVD) or major adverse
cardiovascular events (MACE) in patients with psoriatic arthritis (PsA). Objective To estimate …

Objective. To investigate the prevalence of psoriatic arthritis (PsA) in Japanese patients with
psoriasis. Methods. A multicenter, noninterventional, retrospective cross-sectional study was …

Psoriasis and Psoriatic Arthritis (PsA) are chronic inflammatory diseases that have a major
impact on health. The prevalence and incidence estimates of these two closely related …

Objective To assess the effect of tumor necrosis factor inhibitors (TNF i) on subclinical
cardiovascular disease in patients with psoriatic disease. Methods We performed a 2‐stage …

Psoriasis is a chronic, genetically determined and immunomediated inflammatory skin
disease that affects 2-3% of the Caucasian population. A considerable proportion of these …